Mariam Aslam
PAREXEL International, UK
Scientific Tracks Abstracts: Pharmaceut Reg Affairs
Regulatory Intelligence (RI) has always been an industry practice and is gradually being acknowledged in its own right. RI is an important task to execute when a company is making changes to it medicines and at the same time ensuring the continuation of supply. Three following case studies all demonstrate the importance of gathering RI: 1. Company A updating their pack design and identified that the SPCs need to be updated to align to current guidelines 2. Company B are changing manufacturer of drug product, manufacturing method and also reformulating the excipients. The current manufacturer cannot meet Company B�s current demand 3. Company C changing the legal entity name of manufacturing sites on a global scale These case studies demonstrate that RI should be executed at an early stage to identify and mange risks prior to implementing a regulatory strategy.
Mariam Aslam has 10 years of Regulatory Affairs experience. Her current role is working as a Senior Consultant at PAREXEL International, United Kingdom. Her experience includes working with conventional medicines, herbal medicines, cosmetics and medical devices regulations. She studied a degree in Chemistry at the Manchester Metropolitan University in the UK. Mariam also attended and participated as a moderator and speaker at the OMICS Group Inc 4th 5th International Conference and Exhibition on Pharmaceutical Regulatory Affairs (8-10 September 2014) in Raleigh, NC, USA. Her speech was Herbal Medicines: Product Licence to Traditional Herbal Registration in the UK.
Email: Mariam.Aslam@parexel.com
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report